ContractResearch Agreement • May 14th, 2014 • BioRestorative Therapies, Inc. • Services-misc health & allied services, nec • New York
[Pursuant to 17 C.F.R. 240.24b-2, confidential information has been omitted in places marked “[…***…]” and has been filed separately with the Securities and Exchange Commission pursuant to a Confidential Treatment Application.]
RESEARCH AND DEVELOPMENT AGREEMENTResearch and Development • May 14th, 2014 • BioRestorative Therapies, Inc. • Services-misc health & allied services, nec • New York
THIS RESEARCH AND DEVELOPMENT AGREEMENT (this “Agreement”), dated as of March __, 2014 (the “Effective Date”), is made and entered into by and between BioRestorative Therapies, Inc., a Nevada corporation (“BRT”), and Rohto Pharmaceutical Co., Ltd., a Japanese corporation (“Rohto”) (collectively the “Parties” or individually a “Party”).
RESEARCH AGREEMENT NO. 10028857 AMENDMENT NO. ONE BY AND BETWEEN BIORESTORATIVE THERAPIES, INC. AND THE UNIVERSITY OF UTAHResearch Agreement • May 14th, 2014 • BioRestorative Therapies, Inc. • Services-misc health & allied services, nec
This Research Agreement Amendment Number One (“Amendment”) is entered into and effective as of May 9, 2014 by and between BioRestorative Therapies, Inc., a Nevada corporation (Tax ID #91-1835664), having its principal place of business at 555 Heritage Drive, Jupiter, FL 33458 (“Sponsor”), and the University of Utah, a body politic and corporate of the state of Utah (“University”).
